SDAI Ltd. full year (FY2025) net cash generated from financing activities at SGD 2.06 million

Reuters
02/16
<a href="https://laohu8.com/S/5TI.SI">SDAI</a> Ltd. full year (FY2025) net cash generated from financing activities at SGD 2.06 million

SDAI Ltd. reported its unaudited condensed interim financial statements for the full year ended 31 December 2025. Cash and cash equivalents at the end of the period stood at USD 0.72 million. The company generated USD 2.06 million in net cash from financing activities for the twelve-month period. During the year, SDAI Ltd. expanded into the biotechnology sector with the incorporation of Beijing Blue Code Biotechnology Co., Limited, which was subsequently relocated and renamed Hainan Blue Code Biotechnology Co., Ltd. to optimize tax efficiency. The reported figures have not been audited or reviewed by the independent auditor.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SDAI Ltd. published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: 7AG5V1L542OFLQ23) on February 16, 2026, and is solely responsible for the information contained therein.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10